![]() |
|
|
Vol. 294, Issue 1, 117-125, July 2000
Division of Pharmaceutics, College of Pharmacy (S.-N.H., P.W.S.), and The Ohio State Biophysics Program (P.W.S.), The Ohio State University, Columbus, Ohio
| |
Abstract |
|---|
|
|
|---|
This study addresses the transport mechanism of riboflavin (vitamin B2) across intestinal epithelium in the presence and absence of pharmacologically active compounds. A polarized transport process with a 6-fold higher basolateral (BL)-to-apical (AP) flux was observed in both a human intestinal cell model (Caco-2) and rat intestinal tissue. Riboflavin-specific translocation systems on both the AP and BL cell surfaces were saturable with affinity values close to most receptors (Km: 9.72 ± 0.85 and 4.06 ± 0.03 nM, respectively). Pharmacological agents known to alter intracellular endocytic events were used to examine the potential involvement of receptor-mediated events. Nocodazole significantly inhibited AP uptake (58.4%), BL-to-AP riboflavin (56.7%) and fluorescein isothiocyanate-labeled transferrin (FITC-Tf) (31.8%) transport without affecting mannitol or cholic acid transport, whereas AP-to-BL riboflavin (252.8%) and FITC-Tf (145.1%) transport was increased. Brefeldin A significantly enhanced AP-to-BL riboflavin (37.1%) and bidirectional FITC-Tf transport (AP-to-BL: 13-fold; BL-to-AP: 5-fold). without affecting BL-to-AP riboflavin transport. Combined, these data suggest an essential role of microtubule-dependent movement and vesicular sorting component(s) in the bidirectional transport of riboflavin. Dissociation of riboflavin from the cell surface was pH-dependent with significantly higher substrate release at acidic pH, indicating the presence of riboflavin-specific cell surface receptors. In summary, our studies provide biochemical evidence of the involvement of a receptor-mediated mechanism in the cellular translocation of riboflavin.
| |
Introduction |
|---|
|
|
|---|
The
cell membrane imposes a formidable absorption barrier to the
translocation of water-soluble vitamins. To accommodate the entry of
these essential nutrients, the cell expresses specific membrane
proteins on the cell surface. These proteins are part of a specialized
uptake mechanism that can be broadly categorized as carrier-mediated
and receptor-mediated endocytosis (RME). The first mechanism
facilitates the movement of vitamin molecules across the cell membrane
via membrane carrier protein(s) energized by ATP hydrolysis or the
cotransport of ions moving down their electrochemical gradient. In
fact, transport of most B vitamins has been identified to occur via a
Na+- or H+-dependent
carrier-mediated pathway (Dutta et al., 1999
). In the second model, the
vitamin molecules may first bind to an endogenous protein that in turn
binds to surface receptors (e.g., vitamin B12) or
directly binds receptors localized in specialized membrane regions
(e.g., folate) before they are internalized into endocytic vesicles
(Antony, 1996
).
Cellular uptake of riboflavin, also known as vitamin
B2, has been extensively investigated in a
variety of cell lines, and organs and tissues (intestine, liver, and
kidney) from several species (human, rat, and rabbit) (Said and
Arianas, 1991
; Rindi and Gastaldi, 1997
). From these studies, it
appears that riboflavin is taken up into most cells via an active,
carrier-mediated mechanism that is pH-independent. It has been
suggested that these mechanisms are present on both surfaces of
epithelial cells (Said et al., 1993
; Said and Mohammadkhani, 1993
).
Contradictory results have been reported regarding the influence of
Na+ on riboflavin uptake. Although some studies
suggest no obvious requirement for Na+ or partial
Na+ dependence (Middleton, 1990
; Said and
Arianas, 1991
), most reports indicate riboflavin transport to be
Na+-independent (Said and Ma, 1994
; Dyer and
Said, 1995
). Furthermore, riboflavin uptake is not sensitive to the
Na+/K+-ATPase inhibitor
ouabain (Said and Ma, 1994
; Dyer and Said, 1995
), confirming the
Na+-independent behavior of this transport
system. The apparent Na+,
K+, and H+ (pH)
independence of the riboflavin transport system would classify this
system as a uniporter, challenging the current paradigm that mammalian
apical (AP) solute carrier proteins are predominantly cotransporters
(Hediger et al., 1995
). The outlined controversy surrounding riboflavin
absorption prompted us to explore alternative hypotheses to better
rationalize the uptake mechanism of this important vitamin. Another
possibility for the active cellular uptake of riboflavin is
internalization by surface receptors via a process similar to the RME
of other water-soluble vitamins such as folate and vitamin
B12. In fact, a soluble high-affinity
riboflavin-binding protein has been detected in plasma (Zheng et al.,
1988
) and the reproductive organs of either sex (Natraj et al., 1994
),
although its function in riboflavin transport remains to be defined.
Interestingly, Low and coworkers recently showed the facilitated entry
of BSA into lung epithelial cells and other cell cultures after
covalently coupling BSA to riboflavin (Wangensteen et al., 1996
;
Holladay et al., 1999
). Conjugates were detected in endosomal
compartments, suggesting that BSA-riboflavin conjugates enter the cell
via endocytosis. However, direct evidence of the involvement of
endocytosis and/or transcytosis in the uptake of riboflavin in any cell
type has not been reported previously.
To elucidate the cellular translocation mechanism of riboflavin in the intestine and investigate the potential involvement of an RME component, we have determined its binding and transport in the absence and presence of pharmacologically active compounds that are known to affect vesicular trafficking pathways. We used the well characterized Caco-2 cell line as a model for the small intestine. These cells, when grown to confluence on polymer membrane inserts, mimic the in vivo intestinal absorption process, enabling us to characterize vectorial substrate movement across both cell membranes and the cytoplasm.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials
[3H]Riboflavin (20 Ci/mmol) and [14C]mannitol (60 mCi/mmol) were purchased from Sigma (St. Louis, MO). [3H]Cholic acid (25 Ci/mmol) was from American Radiolabeled Chemicals Inc. (St. Louis, MO). Cell culture materials and buffer solutions were obtained from Life Technologies (Grand Island, NY). Transwell inserts were purchased from Costar (Corning, NY) and rat tail collagen (type I) was from Becton Dickinson Labware (Bedford, MA). Human transferrin (Tf), fluorescein isothiocyanate (FITC) conjugation kit, BCA protein assay kit, nocodazole, and brefeldin A (BFA) were purchased from Sigma. All other chemicals were from Fisher Scientific (Pittsburgh, PA).
Cell Culture
Caco-2 cells were obtained from American Type Culture Collection
(Rockville, MD). Cells with passage numbers 23-38 were maintained at
37°C under 5% CO2 in complete medium
consisting of Dulbecco's modified Eagle's medium with 10%
heat-inactivated fetal bovine serum, 1% nonessential amino acids, 100 U/ml penicillin, 100 µg/ml streptomycin, and 10 mM HEPES. Cells were
plated at 6 × 104
cells/cm2 in tissue culture treated flasks and
used during the exponential growth phase (day 5). Cells were propagated
and cultured as described previously (Hidalgo and Borchardt, 1990
).
Cell monolayers were grown on collagen-coated polycarbonate Transwell
membrane inserts (3.0-µm pore size) at a density of 63,000 cells/cm2. The culture medium was changed every
other day during the 1st week after seeding and daily thereafter.
Protein content was determined by the BCA method using BSA as standard.
Assessment of Transepithelial Membrane Resistance
An epithelial voltohmmeter with dual electrodes (World Precision
Instruments, New Haven, CT) was used to measure transepithelial resistances of monolayers grown on filters as described by Rindler and
Traber (1988)
. Filters were used only if the electrical resistance of
the monolayer exceeded 250
· cm2.
Coincubation with [14C]mannitol (0.2 µCi/ml)
was performed as an independent confirmation that paracellular
transport in monolayers with electrical resistances higher than 250
· cm2 was indeed minimal.
Transepithelial Transport Studies (Caco-2 Cells)
Before transport studies, cell monolayers were washed twice with
warm Dulbecco's PBS and incubated for 30 min at 37°C with substrate-free bathing medium (Hanks' balanced salt solution
containing 25 mM glucose and 10 mM HEPES, adjusted to pH 7.4).
Transport studies were initiated by adding 1.5 to 480 µl of 10 µCi/ml [3H]riboflavin and 30 µl of 10 µCi/ml [14C]mannitol stock solutions to the
donor compartment of pre-equilibrated Caco-2 cell monolayers, thereby
achieving final donor concentrations of 0.5 to 160 nM
[3H]riboflavin and 3.6 µM
[14C]mannitol. The donor compartment volume was
adjusted accordingly to maintain a constant 1.5-ml AP bathing volume.
The transepithelial flux of [3H]riboflavin and
[14C]mannitol from either direction was
followed over time by withdrawing samples at t = 0, 15, 30, 45, 60, 90, 120, 150, and 180 min. To maintain a constant volume,
an identical volume of bathing medium was added back after every
sample. Cell monolayers (14 days postseeding) that exerted a mannitol
flux larger than 0.18%/h/cm2 were excluded from
data analysis (Hidalgo, 1996
). At the end of the experiments, the AP
and basolateral (BL) bathing media were removed. Cell monolayers were
washed three times with ice-cold PBS, pH 7.4, and cells were scraped
off the inserts and processed for liquid scintillation counting.
Transport Studies with Rat Intestinal Tissue
Three-month-old male Sprague-Dawley rats fed ad libitum were
used in all experiments. The small intestine was removed after decapitation, and tissue was prepared for mounting in side-by-side diffusion chambers (Ussing chamber type) as described previously (Swaan
et al., 1994
). Briefly, mucosa was stripped of underlying muscle,
mounted in the Ussing chamber (1-cm2 exposed
surface area), and bathed on both sides with Ringer's buffer solution.
Solutions were circulated by gas lift with carbogen (95%O2, 5%CO2; Liquid
Carbonic, Columbus, OH) and maintained at 38°C (rat body temperature)
by water-jacketed reservoirs. Tissues were equilibrated for 30 min
before initiation of experiments. Potential difference
(Pd) and short-circuit current
(Is.c.) were monitored during the
entire transport experiments to ascertain tissue viability. Tissue
integrity was independently determined by assessing the
[14C]mannitol flux (Marks et al., 1991
). Tissue
viability was further assessed at the end of the study by spiking AP
sides of tissue with a 1 M glucose solution (100 µl); the intestinal
tissues with a 2- to 4-fold Is.c. jump
were considered viable. Is.c. values ranged from 10 to ~25 µEq/h · cm2
to 40 to ~125 µEq/h · cm2 after addition
of D-glucose.
Binding Studies
Caco-2 cells were seeded on 6-well plates and cultured for at least 14 days. Before experiments, cells were washed twice with ice-cold PBS. After incubation at 4°C for 1 h with 2 nM [3H]riboflavin, cells were washed twice with ice-cold PBS (6 ml/well for each 2-min wash) and surface-bound riboflavin was released by incubation with 1 ml of ice-cold PBS with pH values ranging from 3.0 to 8.0 for 2 min. After buffer collection, cells were washed again with 6 ml of ice-cold PBS and finally lysed with 0.5 ml of a 1% Triton X-100 solution. To ascertain mass balance, cell lysates and samples from each PBS washing step were analyzed for radiolabeled material. One nanomolar [14C]mannitol was incorporated in the incubation medium as a control for the specificity of the washing steps. Nonspecific binding and potential passive diffusion was determined in parallel studies by measuring radioactivity bound in the presence of a 1000-fold excess of nonradiolabeled riboflavin. Riboflavin-specific binding was obtained by subtracting nonspecific binding count from the total radioactivity.
Analytical Methods
Radioactivity. The amount of dual-labeled radioactivity in the samples was quantitated using a Beckman liquid scintillation counter (model LS 6000IC; Fullerton, CA) at a counting efficiency of 43 and 75% for 3H and 14C, respectively.
HPLC analysis.
A Beckman HPLC system, consisting of a model
166 UV detector and an LPSX gradient pump, was coupled in series with a
Packard radiometric flow scintillation analyzer (Packard Instruments, Meriden, CT). A Merck reversed phase RP-C18 column (10 cm, 5 µm) was
eluted at 3 ml/min with a scintillation cocktail and 1 ml/min with 87%
10 mM ammonium phosphate (pH 5.5)/acetonitrile (Pietta et al.,
1982
).
Data Analysis and Statistics
Uptake of riboflavin or cholic acid by cell monolayers was
expressed as femtomoles per milligram of protein. Unidirectional flux
was estimated over a period of 0 to 180 min with an observed lag time
of approximately 10 to 15 min. Linearity was observed up to at least
180 min. Values in figures and tables are means ± S.D. of at
least three different experiments with cells from different passages.
The effect of sample withdrawal was taken into account for the
calculation of fluxes using the following equation:
|
(1) |
|
(2) |
| |
Results |
|---|
|
|
|---|
Effect of Culture Time on Riboflavin Transport.
Within 10 days
after achieving confluency, Caco-2 cells undergo a differentiation
program that involves formation of tight junctions (as assessed by
changes in electrical resistance across monolayers grown on filters)
and marked elevations in the levels of several brush border hydrolases
and transport proteins (Delie and Rubas, 1997
). When grown on filters,
this proliferation and differentiation program yields a functional
monolayer of cells strongly resembling the small intestinal epithelium.
It has been shown previously that the transepithelial transport level
of some nutrients such as biotin and vitamin B12
across these monolayers can vary significantly with days in culture,
depending on their specific membrane transport protein expression
during differentiation (Dix et al., 1990
; Ng and Borchardt, 1993
).
Thus, we first investigated the optimal culture time for maximal
expression of riboflavin transport protein(s). In this experiment, we
chose a [3H]riboflavin concentration in
accordance with the baseline riboflavin concentration in human plasma
(~12 nM) (Zempleni et al., 1996
). [14C]Mannitol was used as a control to
ascertain monolayer integrity. This compound uniquely diffuses across
the cell membrane via the paracellular pathway, providing a
quantitative measure of tight junctional development in maturing Caco-2
cell monolayers (Marks et al., 1991
, Swaan et al., 1994
).
|
Metabolic Stability of [3H]Riboflavin.
In
addition to formation of tight junctions, functional differentiation in
Caco-2 cells is accompanied by elevated expression of several metabolic
enzymes. Multiple studies have shown that enzymatic activities
gradually increase during differentiation and reach maximal levels 15 to 21 days after confluency (reviewed by Delie and Rubas, 1997
). It has
also been suggested that phosphorylation of riboflavin inside
enterocytes is an essential step of its AP absorption (Kasai et al.,
1988
). To investigate whether putative enzymatic conversion and
metabolic instability of [3H]riboflavin (which
contains a general tritium label) could contribute to the observed
transport polarity, we analyzed samples from transport experiments on
an HPLC system coupled to a radiometric liquid scintillation detector.
Chromatograms of samples after a 3-h transport study (Fig.
2) indicated that most radiolabeled
riboflavin on the donor side remains unchanged (Fig. 2, B and C),
although we cannot exclude the possibility that any metabolites are
below the limit of detection on this system. On the AP acceptor side, 85% of transported ligand remains in the form of unchanged riboflavin (Fig. 2A), whereas the remaining activity cannot be ascribed to the
major coenzyme forms of riboflavin, FMN and FAD, which would elute at
2.5 and 3.0 min, respectively.
|
Polarization of Riboflavin Transport in Rat Tissue.
Although
the Caco-2 cell culture system is known to closely mimic small
intestinal enterocytes, it has been reported that these cells exert
slightly different biochemical indices and constitute altered protein
composition and expression when compared with human small intestinal
enterocytes. To further validate that the observed transport polarity
of riboflavin did not reflect a cellular aberration inherent to the
biochemical differences between Caco-2 cells and human intestinal
epithelial cells in vivo, we conducted transport studies using rat
intestinal tissues mounted in side-by-side diffusion chambers (Ussing
chamber type). Figure 3 shows that riboflavin transport in rat intestine from both directions is linear up
to 180 min with a significantly greater BL-to-AP flux (approximately
5-fold, 577.5 fmol/h/cm2;
R2 = 0.99) over AP-to-BL flux (124.9 fmol/h/cm2; R2 = 0.98).
|
Concentration Dependence of Riboflavin Transport.
The observed
polarization in transepithelial transport of riboflavin could be
attributed to the presence of two different transport systems located
on the AP and BL sides of the membrane. To test this possibility,
concentration-dependence experiments were carried out in both transport
directions. Figure 4 demonstrates that
riboflavin is transported by a binary mechanism consisting of both a
saturable and a linear (passive) component. At concentrations near
basal plasma riboflavin concentrations, riboflavin is transported predominantly by the saturable component. Table
1 lists the kinetic parameters of the
transport systems on both sides of the epithelium. Consistent with our
findings (previous sections) that riboflavin transport is greater in
the BL-to-AP direction, we determined that a BL transport system
had a 2-fold higher affinity (Km)
compared with the AP translocation system. These results suggest that
the higher BL-to-AP riboflavin transport is partly due to the higher affinity of riboflavin for the BL system.
|
|
Effect of Endocytosis Inhibitors on Riboflavin Transport.
The
affinity values (Km) for
carrier-mediated transport pathways are generally in the micromolar
range, whereas most receptor-mediated processes exert substrate
affinity values in the low nanomolar range (Feener and King, 1998
).
Concentration-dependence studies reveal two high-affinity riboflavin
transport systems with Km values in
the low nanomolar range (Table 1). Therefore, our results suggest the
involvement of a receptor-mediated mechanism in the transepithelial
transport of riboflavin. Moreover, most receptor-mediated transcytosis
systems transport their substrates preferentially in the BL-to-AP
direction (Okamoto, 1998
). The interesting consistency between these
observations and our current results led us to hypothesize that
cellular uptake of riboflavin may use an RME/transcytosis mechanism
similar to that of other vitamins in the B group, e.g., folate and
vitamin B12. Without the availability of a cDNA
clone of the postulated transporter/receptor, it is relatively
difficult to distinguish between RME and carrier-mediated pathways
using contemporary biochemical or electrophysiological techniques
because both mechanisms reveal characteristics of active transport
processes. However, several inhibitors are known to affect specific
processes and/or organelles involved in vesicle trafficking, protein
sorting, RME, and transcytosis. To directly test our hypothesis, two
inhibitors with different mechanisms of action were chosen: nocodazole
and BFA. At the cellular level, nocodazole inhibits endocytosis by depolymerizing microtubules (Hamm-Alvarez and Sheetz, 1998
), which are
necessary for endocytic vesicles to move within the cell, and BFA
induces missorting of vesicles in the trans-Golgi network (Wan et al., 1992
).
|
pH-Dependent Dissociation of Surface-Bound Riboflavin.
An
additional distinct mechanistic feature of ligands for RME pathways is
pH-dependent dissociation of these molecules from their receptors
(reviewed by Mukherjee et al., 1997
). Consequently, we performed
surface binding experiments at 4°C using wash buffers with pH values
of 3 to 8. At 4°C, the cellular internalization of riboflavin is
significantly blocked (data not shown). Nonspecific binding is
determined from parallel studies in the presence of a 1000-fold excess
of unlabeled riboflavin, and [14C]mannitol
binding serves as a negative control. A decrease in pH from 8 to 3 resulted in elevated dissociation of riboflavin from its specific
binding site(s) with significantly greater amounts of riboflavin
released at pH 3 and 4, whereas the release of mannitol is
pH-independent (Fig. 6). At physiological
pH of the small intestinal lumen (pH 6-7), riboflavin shows higher
binding interaction to its cell surface receptors.
|
| |
Discussion |
|---|
|
|
|---|
Although multiple studies have characterized the uptake mechanism of riboflavin in a variety of tissues and species, there is surprisingly little information on the transepithelial transport of riboflavin across different cell types. In this study, we find that at concentrations around its Km, riboflavin transport from the BL to the AP surface is 6-fold greater, compared with the flux in the AP-to-BL direction. This elevated transport from the systemic circulation into gut lumen has not been observed previously either in cell culture systems (Fig. 1) or in intestinal tissue preparations (Fig. 3). The fact that transport polarity is conserved between two different species (rat versus human) further confirms the physiological and biological relevance of this observation. It also validates that the striking polarity of riboflavin transport observed in Caco-2 cells is not due to a transport anomaly specific to this particular cell line.
Interestingly, a similar transport polarity has been reported for
intestinal Tf absorption (Shah and Shen, 1994
) with a 40-fold difference in BL-to-AP versus AP-to-BL translocation activity and receptor expression. Enterocytes are known to obtain iron from
dietary iron uptake and, during periods of low dietary iron intake,
also from body iron stores. Analogous to intestinal iron homeostasis,
we anticipate that intracellular riboflavin levels in the gut are
tightly regulated as well. Therefore, the putative physiological
function of the riboflavin receptor on the BL surface of enterocytes is
to participate in the supply of riboflavin to maturing epithelial
cells. Because the intestine has the highest cell turnover rate of any
tissue, a continuous supply of riboflavin would be required to support
cell growth and differentiation as well as the synthesis of essential
flavoproteins such as digestive enzymes.
The Km values we reported from
transport experiments (Table 1) are 100-fold lower than those reported
by Said and coworkers, who found values in the low micromolar range
(0.3 µM) via uptake studies (Said and Ma, 1994
). It is essential,
however, to point out two consequential differences between the
previous studies and our data. First, transepithelial transport in
polarized cells comprises a series of sequential events, namely
ligand-binding, internalization, ligand movement through the cytoplasm,
and translocation across two cell membranes with different lipid
compositions. Uptake experiments can only discern binding and movement
through the AP membrane. Second, we selected riboflavin concentrations
according to the reported basal human serum level (12 nM), whereas
earlier studies cover higher concentrations in the micromolar domain. If more than one type of riboflavin transport system exists in Caco-2
cells, the higher affinity system would not be detected at ligand
concentrations 10-fold greater than the
Km value of this system. Therefore,
the possibility exists that small intestinal cells adopt two different
membrane transport mechanisms for riboflavin with unequal substrate
affinity. Interestingly, this observation correlates with the previous
discovery of two unique coexisting transport systems for folic acid,
another member of the B-vitamin group. It is now widely accepted that
the cellular uptake of this essential molecule is mediated by both a
glycosylphosphatidylinositol-anchored receptor with a
Km of 0.1 nM and a transmembrane
carrier protein with an apparent Km of
1 µM (reviewed by Reddy and Low, 1998
). These findings and our
current observation may suggest that more unique high-affinity
transport mechanisms could exist for other members of the B-vitamin group.
In intestinal epithelial cells, microtubules extend in straight arrays
from the AP to the BL cell membrane, providing an essential network for
many membrane-trafficking events including endocytosis and transcytosis
(Hamm-Alvarez and Sheetz, 1998
). Disruption of microtubules with
nocodazole significantly inhibits BL-to-AP transport of riboflavin
(Fig. 5A). These results are in good agreement with the data by
Maples et al. (1997)
, who reported a 50 to 75% inhibition of
the BL-to-AP transcytosis of polymeric IgA in Madin-Darby canine kidney cells in the presence of nocodazole. More importantly, nocodazole inhibition of the BL-to-AP flux of FITC-Tf, a
well-characterized RME substrate, suggests that these two compounds
share similar microtubule-dependent intracellular trafficking pathways.
Specificity of nocodazole for RME processes, but not carrier-mediated
events, was shown by the apparent lack of reduction in cholic acid
flux. This observation, in turn, rules out the possibility that our data are a reflection of cellular damage caused by the adverse effects
of nocodazole on protein synthesis and signal transduction (Hamm-Alvarez and Sheetz, 1998
).
It has been reported that polarized epithelial cells have spatially
separated early endosomal systems governing distinct bidirectional endocytosis/transcytosis processes (Mukherjee et al., 1997
). These two
pathways are also functionally distinct in their sensitivities toward
pharmacological agents (Okamoto, 1998
). Interestingly, nocodazole
treatment results in increased AP-to-BL transport of both riboflavin
and FITC-Tf (Fig. 5B). Currently, the factors underlying this
phenomenon are not completely understood and need further investigation.
Even though AP and BL endosomal systems are separately regulated in
epithelial cells, studies in Caco-2 cells have revealed an
interconnection via intermediate endosomes and common recycling compartments (Knight et al., 1995
). BFA is known to cause intracellular missorting of ligand-receptor complexes within the endosome-trans-Golgi network, a region closely involved in vesicular sorting and
bidirectional endocytosis/transcytosis (Wan et al., 1992
). In our
studies, BFA results in a significant increase in AP-to-BL transport of
riboflavin and FITC-Tf without perturbing the cholic acid flux.
BL-to-AP riboflavin transport is slightly, but not significantly,
reduced (P > .05). These results are consistent with
previous studies showing that BFA induces TfR-mediated transcytosis of
125I-Tf across Caco-2 cell monolayers in both
transport directions (Shah and Shen, 1994
). These observations are also
in agreement with the findings that BFA treatment leads to enhanced
transcytosis of ricin and Clostridium botulinum
neurotoxin (Prydz et al., 1992
; Maksymowych and Simpson, 1998
). Shen
and colleagues demonstrated that enhancement of Tf transcytosis by BFA
is accompanied by a significant increase in the number of TfRs on the
AP cell membrane and a decrease in the number of TfRs on the BL cell
membrane without affecting total TfR expression (Wan et al., 1992
; Shah
and Shen, 1994
). Whether a similar mechanism is responsible for
increased riboflavin transport remains to be investigated.
Our finding that dissociation of riboflavin from its specific surface
binding site(s) is pH-dependent (Fig. 6) provides additional biochemical evidence corroborating our hypothesis. This observation is
consistent with a hallmark feature of RME in which acidification of
endosomes during the endocytic sorting process causes dissociation of
ligands from receptors. pH-sensitive binding has been reported previously for folate and vitamin B12, both
well-characterized ligands using RME mechanisms (Kamen and Capdevila,
1986
).
In summary, our experiments demonstrate that a specialized, high-affinity riboflavin translocating system(s) exists in the intestinal cells with affinity values and biochemical characteristics similar to most receptor-mediated systems reported in the literature. This system is primarily expressed on the BL surface. Although the physiological role behind this type of polarity needs to be further investigated, our findings suggest that the BL uptake system could play an important role in supplying nutrients to the highly proliferative intestinal epithelium. These data aid in our understanding of the transepithelial transport mechanism of riboflavin and the proteins involved in its uptake and contribute to our knowledge of human riboflavin homeostasis and the physiology of B vitamins in general.
| |
Acknowledgment |
|---|
We thank Dr. Michael Darby at the Ohio State University Comprehensive Cancer Center for kind assistance with the use of the radiometric HPLC system.
| |
Footnotes |
|---|
Accepted for publication March 10, 2000.
Received for publication December 16, 1999.
Send reprint requests to: Dr. Peter W. Swaan, Division of Pharmaceutics, College of Pharmacy, 500 West 12th Ave., Columbus OH 43210-1291. E-mail: swaan.1{at}osu.edu
| |
Abbreviations |
|---|
RME, receptor-mediated endocytosis; FITC-Tf, fluorescein isothiocyanate-labeled transferrin; TfR, transferrin receptor; AP, apical; BL, basolateral; BFA, brefeldin A; Is.c., short-circuit current.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Yonezawa, S. Masuda, T. Katsura, and K.-i. Inui Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1 Am J Physiol Cell Physiol, September 1, 2008; 295(3): C632 - C641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Foraker, A. Ray, T. C. Da Silva, L. M. Bareford, K. M. Hillgren, T. D. Schmittgen, and P. W. Swaan Dynamin 2 Regulates Riboflavin Endocytosis in Human Placental Trophoblasts Mol. Pharmacol., September 1, 2007; 72(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. van Herwaarden, E. Wagenaar, G. Merino, J. W. Jonker, H. Rosing, J. H. Beijnen, and A. H. Schinkel Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk Mol. Cell. Biol., February 15, 2007; 27(4): 1247 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Mason, V. M. D'Souza, L. M. Bareford, M. A. Phelps, A. Ray, and P. W. Swaan Recognition, Cointernalization, and Recycling of an Avian Riboflavin Carrier Protein in Human Placental Trophoblasts J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Huang, M. A. Phelps, and P. W. Swaan Involvement of Endocytic Organelles in the Subcellular Trafficking and Localization of Riboflavin J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Huang and P. W. Swaan Riboflavin Uptake in Human Trophoblast-Derived BeWo Cell Monolayers: Cellular Translocation and Regulatory Mechanisms J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 264 - 271. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||